Operations
We manufacture, package and distribute our products through a state-of-the-art network of facilities strategically located throughout the U.S., India and Ireland. Our operations capabilities are diverse and distinct, with few competitors matching our breadth of manufacturing expertise across all dosage forms, including complex oral solids, softgels, injectables, ophthalmics, liquids, topicals and transdermals.
We also maintain robust internal active pharmaceutical ingredient (API) manufacturing capabilities as well as advanced packaging and distribution facilities. Over the last several years, we have invested considerably in advanced equipment, technologies and talent – all to ensure the safe and reliable production of our products.
Bridgewater, NJ
Headquarters, Specialty/Complex R&D
Piscataway, NJ
Oral Solids, Topicals, Transdermals, High Potency and Hormonal Products
Branchburg, NJ
Oral Liquid Products, Nasal Sprays
Glasgow, KY
Sales Operations, Distribution
East Hanover, NJ
Primary Packaging
Brookhaven, NY
Oral Solids, Soft Gel, High Potency and Hormonal Products
Hauppauge, NY
Oral Solids
Vizag, India
Active Pharmaceutical Ingredients (API)
Hyderabad, India
Oncology
Ahmedabad, India
5 Facilities:
2 Oral Solids, 3 Injectables
DaheJ, India
Active Pharmaceutical Ingredients (API)
Cashel Ireland
Inhalation
Bridgewater, NJ
Headquarters, Specialty/Complex R&D
Piscataway, NJ
Oral Solids, Topicals, Transdermals, High Potency and Hormonal Products
Branchburg, NJ
Oral Liquid Products, Nasal Sprays
Glasgow, KY
Sales Operations, Distribution
East Hanover, NJ
Primary Packaging
Brookhaven, NY
Oral Solids, Soft Gel, High Potency and Hormonal Products
Hauppauge, NY
Oral Solids
Vizag, India
Active Pharmaceutical Ingredients (API)
Hyderabad, India
Oncology
Ahmedabad, India
5 Facilities:
2 Oral Solids, 3 Injectables
DaheJ, India
Active Pharmaceutical Ingredients (API)
Cashel Ireland
Inhalation
Amneal expands capability and capacity for growing
injectables business
On November 3, 2021, Amneal acquired Puniska Healthcare, an India-based manufacturer of parenteral and injectable drugs. The acquisition, now part of Amneal Pharmaceutical Pvt. Ltd, significantly enhances our injectables manufacturing infrastructure, boosts capacity to support the U.S. market and serves as a foundation for our expansion into international markets.